Latest News and Press Releases
Want to stay updated on the latest news?
-
Revenue increased 6.2% to $302.2 million Net income was $36.7 million, or $2.59 per diluted share, excluding gain on sales of assets Operating cash flow totaled $64.5 million SAN CLEMENTE,...
-
SAN CLEMENTE, Calif., Jan. 19, 2012 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI), ICU Medical, Inc., a leader in the development, manufacture and sale of innovative medical devices used in...
-
SAN CLEMENTE, Calif., Dec. 28, 2011 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical technologies used in I.V. therapy,...
-
SAN CLEMENTE, Calif., Dec. 22, 2011 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical technologies used in I.V. therapy,...
-
SAN CLEMENTE, Calif., Nov. 16, 2011 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical technologies used in I.V. therapy,...
-
Third Quarter Earnings Per Share of $0.65 Company Raises Annual 2011 Revenue and Earnings Per Share Guidance Range SAN CLEMENTE, Calif., Oct. 17, 2011 (GLOBE NEWSWIRE) -- ICU Medical, Inc.,...
-
SAN CLEMENTE, Calif., Oct. 6, 2011 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI), today announced the time of its third quarter 2011 earnings release conference call. ICU Medical, Inc....
-
SAN CLEMENTE, Calif., Aug. 29, 2011 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI), a leader in innovative products used in vascular therapy, oncology and critical care applications, today...
-
Diluted EPS Increased 18% to $0.67 Sales Grew 13% to $77.8 Million SAN CLEMENTE, Calif., July 18, 2011 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI), a leader in the development,...
-
SAN CLEMENTE, Calif., July 6, 2011 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI), today announced the time of its second quarter 2011 earnings release conference call. ICU Medical, Inc....